1. Mansur RB, Ahmed J, Cha DS, Woldeyohannes HO, Subramaniapillai M, Lovshin J, et al. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study. J Affect Disord. 2017 Jan 1;207:114–20.
2. Seeberg I, Kjaerstad HL, Miskowiak KW. Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review. Front Psychiatry. 2018;9. Available from: https://www.frontiersin.org/articles/ 10.3389/fpsyt.2018.00337/full
3. Cognitive dysfunction in major depression and bipolar disorder: Assessment and treatment options - MacQueen - 2017 - Psychiatry and Clinical Neurosciences - Wiley Online Library. Available from: https://onlinelibrary.wiley.com/ doi/full/10.1111/pcn.12463
4. Zuckerman H, Pan Z, Park C, Brietzke E, Musial N, Shariq AS, et al. Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder. Front Psychiatry. 2018;9. Available from: https://www.frontiersin.org/articles/ 10.3389/fpsyt.2018.00655/full
5. Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, et al. Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disord. 2017 Dec;19(8):614–26.
6. Mansur RB, Lee Y, Subramaniapillai M, Brietzke E, McIntyre RS. Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists? Neuropharmacology. 2018 Jul 1;136:335–42.
7. Picó-Pérez M, Radua J, Steward T, Menchón JM, Soriano-Mas C. Emotion regulation in mood and anxiety disorders: A meta-analysis of fMRI cognitive reappraisal studies. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79:96–104.
8. Haroon E, Miller AH, Sanacora G. Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders. Neuropsychopharmacology. 2017 Jan;42(1):193–215.
9. Cuperfain AB, Kennedy JL, Gonçalves VF. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder. Neurosci Biobehav Rev. 2020 Apr 1;111:125–34.
10. McIntyre RS, Mansur RB, Lee Y, Japiassú L, Chen K, Lu R, et al. Adverse effects of obesity on cognitive functions in individuals at ultra high risk for bipolar disorder: Results from the global mood and brain science initiative. Bipolar Disord. 2017;19(2):128–34
11. Cotter J, Granger K, Backx R, Hobbs M, Looi CY, Barnett JH. Social cognitive dysfunction as a clinical marker: A systematic review of meta-analyses across 30 clinical conditions. Neurosci Biobehav Rev. 2018 Jan 1;84:92–9.
12. Penton-Voak IS, Munafò MR, Looi CY. Biased Facial-Emotion Perception in Mental Health Disorders: A Possible Target for Psychological Intervention? Curr Dir Psychol Sci. 2017 Jun 1;26(3):294–301.
13. Cipriani G, Danti S, Carlesi C, Cammisuli DM, Di Fiorino M. Bipolar Disorder and Cognitive Dysfunction: A Complex Link. J Nerv Ment Dis. 2017 Oct;205(10):743–56.
14. Rheenen TEV, Lewandowski KE, Bauer IE, Kapczinski F, Miskowiak K, Burdick KE, et al. Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence. Bipolar Disord. 2020;22(1):13–27.
15. Su K-P, Lai H-C, Peng C-Y, Su W-P, Chang JP-C, Pariante CM. Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder. Brain Behav Immun. 2019 Aug 1;80:512–8.
16. Green MJ, Girshkin L, Kremerskothen K, Watkeys O, Quidé Y. A Systematic Review of Studies Reporting Data-Driven Cognitive Subtypes across the Psychosis Spectrum. Neuropsychol Rev. 2020 Dec 1;30(4):446–60.
17. Bora E. Neurocognitive features in clinical subgroups of bipolar disorder: A meta-analysis. J Affect Disord. 2018 Mar 15;229:125–34.
18. Lee C-Y, Lee S-Y, Huang Y-C, Hung C-F, Lee Y, Lee M-I, et al. The Chinese version of the Brief Assessment of Cognition in Affective Disorders: normative data of a Mandarin-speaking population. Clin Neuropsychol. 2018 Nov 30;32(sup1):1–14.
19. McIntyre RS, Florea I, Tonnoir B, Loft H, Lam RW, Christensen MC. Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder. J Clin Psychiatry. 2017 Jan 25;78(1):115–21.
20. Xu N, Huggon B, Saunders KEA. Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment. CNS Drugs. 2020 Jan 1;34(1):29–46.
21. Safety of intranasal human insulin: A review - Schmid - 2018 - Diabetes, Obesity and Metabolism - Wiley Online Library. Available from: https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.13279
22. Soria V, González-Rodríguez A, Huerta-Ramos E, Usall J, Cobo J, Bioque M, et al. Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis. Psychoneuroendocrinology. 2018 Jul 1;93:8–19.
23. Douglas KM, Jordan J, Inder ML, Crowe MT, Mulder R, Lacey C, et al. Cognitive Remediation for Outpatients With Recurrent Mood Disorders: A Feasibility Study. J Psychiatr Pract. 2020 Jul;26(4):273–83.
24. Basso JC, Suzuki WA. The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, anatomy;Neurochemical Pathways: A Review. Brain Plast. 2017 Jan 1;2(2):127–52.
25. Yang L-L, Zhao D, Kong L-L, Sun Y-Q, Wang Z-Y, Gao Y-Y, et al. High-frequency repetitive transcranial magnetic stimulation (rTMS) improves neurocognitive function in bipolar disorder. J Affect Disord. 2019 Mar 1;246:851–6.
26. Martin DM, McClintock SM, Forster JJ, Lo TY, Loo CK. Cognitive enhancing effects of rTMS administered to the prefrontal cortex in patients with depression: A systematic review and meta-analysis of individual task effects. Depress Anxiety. 2017;34(11):1029–39.